Sun Pharmaceutical Industries Ltd spurts 0.66%, up for five straight sessions> |
Sun Pharmaceutical Industries Ltd - Sun Pharmaceutical Industries Limited - Updates> |
Sun Pharma announces top-line results of tildrakizumab 100 mg Phase 3 studies> |
Sun Pharmaceutical Industries Ltd - Announcement under Regulation 30 (LODR)-Press Release / Media Release> |
Sun Pharmaceutical Industries Ltd - Sun Pharmaceutical Industries Limited - Copy of Newspaper Publication> |
Sun Pharmaceutical Industries Ltd - Sun Pharmaceutical Industries Limited - Press Release> |
Sun Pharmaceutical Industries Ltd - Sun Pharmaceutical Industries Limited - Other General Purpose> |
Sun Pharmaceutical Industries Ltd spurts 2.56%, rises for third straight session> |
Sun Pharma launches Leqselvi in US; settles litigation with Incyte Corp> |
Sun Pharmaceutical Industries Ltd - Announcement under Regulation 30 (LODR)-Newspaper Publication> |